Daily Medication Pearl: Fosamprenavir Calcium (Lexiva)

Article

Fosamprenavir calcium (Lexiva ) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

Medication Pearl of the Day: Fosamprenavir Calcium (Lexiva)

Indication: Fosamprenavir calcium (Lexiva) is an HIV protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

Insight:

  • Dosing:Therapy-naive adults, Lexiva 1400 mg twice daily; Lexiva 1400 mg once daily plus ritonavir 200 mg once daily.
  • Dosage forms: 700 mg tablets and 50 mg/mL oral suspension.
  • Adverse events:In adults, the most common adverse reactions (incidence ≥4%) are diarrhea, rash, nausea, vomiting, and headache.
  • Mechanism of action: Fosamprenavir is an antiviral agent.

Source: Lexiva Label (fda.gov)

Related Videos
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Mayo Clinic oncology pharmacy
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
pharmacy | Image Credit: Diego Cervo - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.